The compounds are substituted hydrazinophthalazines which are active as .beta.-adrenergic blocking agents and as vasodilators. A specific compound of the invention is 5-(3-t-butylamino-2-hydroxypropoxy)-1-hydrazinophthalazine.
这些化合物是替代的
肼基邻苯二酮,作为β-
肾上腺素受体阻滞剂和血管扩张剂具有活性。该发明的特定化合物是5-(3-t-丁基
氨基-2-羟基丙氧基)-1-
肼基邻苯二酮。